Abby Macnish
Vermögen: 38 038 $ am 31.05.2026
Vermögen: 38 038 $ am 31.05.2026
Abby Niven Macnish is currently Director at Muscular Dystrophy Wa and Neuromuscular Wa, Member of the Australian Institute of Co. Directors, Chief Financial Officer & Secretary at Paradigm Biopharmaceuticals Ltd. since 2023, and Secretary at Atomic Eagle Ltd. since 2026.
Former roles include Chief Financial Officer & Secretary at Neuroscientific Biopharmaceuticals Ltd. from 2020 to 2024, and Chief Financial Officer & Secretary at Tombador Iron Ltd. Education includes undergraduate studies at The University of Western Australia.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0.03% | 31.12.2025 | 128’746 ( 0.03% ) | 37 979 $ | 31.05.2026 |
Alterity Therapeutics Ltd.
Alterity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs 0% | 09.04.2026 | 9’091 ( 0% ) | 59 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PARADIGM BIOPHARMACEUTICALS LIMITED | Finanzdirektor/CFO | 03.03.2023 |
Muscular Dystrophy Wa | Direktor/Vorstandsmitglied | - |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED | Finanzdirektor/CFO | 06.02.2024 |
| RESA GROUP LIMITED | Finanzdirektor/CFO | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Tombador Iron Ltd.
Tombador Iron Ltd. SteelNon-Energy Minerals Explores and sells iron ores | Non-Energy Minerals |
The University of Western Australia
The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Paradigm Biopharmaceuticals Ltd.
Paradigm Biopharmaceuticals Ltd. Pharmaceuticals: GenericHealth Technology Engages in repurposing the drug, pentosan polysulphate sodium for the treatment of bone marrow edema | Health Technology |
Neuroscientific Biopharmaceuticals Ltd.
Neuroscientific Biopharmaceuticals Ltd. BiotechnologyHealth Technology Engages in researching and developing pharmaceutical products | Health Technology |
Muscular Dystrophy Wa |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen